DELCATH SYSTEMS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
DELCATH SYSTEMS, INC. (DCTH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $1.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-06
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $900.00K, a 35.71% decline year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $200.00K, a 75.00% decline year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $800.00K, a 700.00% increase year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $3.00M, a 200.00% increase from fiscal 2024.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $1.00M, a 900.00% increase from fiscal 2023.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $100.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.10M 10-Q · filed 2026-08-06 | $1.10M derived: sum of 3 quarters · filed 2026-08-06 | $1.90M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-07 | $200.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.00M derived: sum of 3 quarters · filed 2026-05-07 | $2.40M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $800.00K derived: sum of 2 quarters · filed 2026-02-26 | $2.20M derived: sum of 3 quarters · filed 2026-08-06 | $3.00M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.20M derived: sum of 2 quarters · filed 2026-08-06 | $3.00M 10-Q · filed 2025-11-04 | $3.80M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.20M 10-Q · filed 2026-08-06 | $3.00M derived: sum of 3 quarters · filed 2026-08-06 | $3.10M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $800.00K 10-Q · filed 2026-05-07 | $1.60M derived: sum of 2 quarters · filed 2026-05-07 | $1.70M derived: sum of 3 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $900.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.00M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $200.00K 10-Q · filed 2025-11-04 | $221.00K 10-Q · filed 2024-11-08 | ||||
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-06 | $60.00K 10-Q · filed 2024-08-05 | |||||
| 2023-12-31 | $100.00K 10-K · filed 2025-03-06 | $1.00K 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| CARLSMED, INC. (CARL) | United States | $0.405B |